MDS

From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.

The Food and Drug Administration approved Tibsovo for patients with relapsed or refractory myelodysplastic syndromes with a susceptible isocitrate dehydrogenase-1 mutation.

COVID is unpredictable and scary, much like cancer.

Trust me, I made the mistake of blaming every symptom on my cancer.

Reblozyl for anemia in patients with an MDS subset demonstrated positive effects, compared with previous treatments, according to an MDS expert.

Hematopoietic cell transplantation improved survival among high-risk genetic subgroups of patients with myelodysplastic syndrome, a recent study found.

As The Los Angeles Rams celebrate a cancer survivor and a 9/11 survivor reveals his fourth cancer diagnosis, this is what’s happening in the oncology space this week.

Here’s a look back at blood cancer approvals from the summer of 2023.

The Food and Drug Administration approved Reblozyl to treat low red blood cell count in patients with very low- to intermediate-risk myelodysplastic syndrome.

The Food and Drug Administration granted a priority review to Tibsovo for the treatment of patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome.

Patients with myelodysplastic syndrome should seek an expert opinion on their disease to ensure an accurate diagnosis and proper treatment plan.

I was devastated when I had to stop working due to my cancer diagnosis. However, I eventually found a new line of work that I'm grateful for.

Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too.

The bonds that you make with your doctors can last a lifetime, and I’m so glad to call many of them a friend.

Reblozyl treatment in patients with anemia from lower-risk myelodysplastic syndromes achieved a greater independence from red blood cell transfusions compared with treatment with epoetin alfa.

Patients with lower risk myelodysplastic syndrome may now receive imetelstat — despite it not being FDA-approved.

I experienced unexpected rewards of decluttering.

Cancer taught me not to worry about the little things.

Sometimes I feel lazy and berate myself instead of admitting that I am ill.

Acute myeloid leukemia and myelodysplastic syndrome may affect nutritional status, and more work is needed to ensure that patients are getting the food intake that they need, researchers found.

Slowing down due to cancer and COVID-19 made me realize the parts of life I’ve been missing, though my new pace isn’t all bad.

As a cancer survivor, I feel that the song, "Here comes the sun" can inspire us all.

I’m happy to be alive and thankful for all that I have, but cancer and the COVID-19 pandemic has taken so much from me, physically, emotionally and financially.

My oncology team works together to take great care of myself and other patients.

A book I read made me realize the importance of positive thinking — even when going through cancer.

Muscle aches related to cancer treatment were having a major impact on my life.

My family is scattered throughout the country, so I often rely on friends to lend a helping hand.

Imetelstat improves eight- and 24-week transfusion independence in patients with low-risk myelodysplastic syndrome, according to topline study results.

As a cancer survivor, the COVID-19 pandemic continues to affect me and force me to miss activities — and people — I love.

One patient describes the management of symptoms of graft-versus-host disease as playing Whac-a-Mole and emphasizes the importance of awareness and education for both patients and their families.